GlaxoSmithKline | Vermögenswerte



Assets Veränderung Datum
AbbVie USD 136.17B 1B 2025-03
Alcon AG USD 31.01B 661M 2025-03
Almirall EUR 2.31B 88.18M 2025-06
Amgen USD 87.9B 1.47B 2025-06
argenx SE 7.18B 973.07M 2025-06
AstraZeneca USD 112.42B 6.17B 2025-06
Bayer EUR 109.18B 1.67B 2025-03
Biogen USD 28.33B 297.1M 2025-06
Bristol-Myers Squibb USD 94.68B 2.25B 2025-06
Eli Lilly USD 100.92B 11.53B 2025-06
Fresenius EUR 43.21B 343M 2025-03
Fresenius Medical Care EUR 32.74B 832M 2025-03
Galapagos EUR 3.82B 203.72M 2025-06
Genmab DKK 6.59B 39.22B 2025-03
Gilead Sciences USD 55.72B 713M 2025-06
GlaxoSmithKline GBP 59.26B 1.45B 2025-06
Glaxosmithkline GBP 59.46B 1.41B 2024-12
GRIFOLS EUR 19.77B 1.21B 2025-06
Hikma Pharmaceutical USD 5.13B 286M 2024-12
Lonza CHF 19.73B 1.85B 2024-12
Merck EUR 47.35B 2.02B 2025-06
Merck USD 117.52B 2.4B 2025-06
Novartis USD 104.4B 4.45B 2025-06
Novo Nordisk 482.15B 7.01B 2025-06
Orion EUR 1.65B 56M 2025-06
Pfizer USD 206.1B 1.93B 2025-06
Philips EUR 26.38B 788M 2025-06
Recordati EUR 5.18B 9.99M 2025-06
Regeneron Pharmaceuticals USD 38.22B 674M 2025-06
Roche Holding CHF 101.8B 6.02B 2024-12
Sanofi 124.96B 6.93B 2025-06
Smith & Nephew USD 10.69B 338M 2025-06
UCB EUR 17.35B 1.72B 2024-12


GlaxoSmithKline Vermögenswerte - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.